Innovation1 Biotech (Innovation1 Biotech) Debt-to-Asset : 3.01 (As of Aug. 2023)

Innovation1 Biotech Debt-to-Asset Chart

Innovation1 Biotech Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23
Debt-to-Asset		Get a 7-Day Free Trial				0.30	4.02	0.88	0.01	3.01

Innovation1 Biotech Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Debt-to-Asset	Get a 7-Day Free Trial															0.01	0.11	0.01	0.03	3.01

Competitive Comparison of Innovation1 Biotech's Debt-to-Asset

For the Shell Companies subindustry, Innovation1 Biotech's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovation1 Biotech's Debt-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Innovation1 Biotech's Debt-to-Asset falls into.

Innovation1 Biotech Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Innovation1 Biotech's Debt-to-Asset for the fiscal year that ended in Aug. 2023 is calculated as

Innovation1 Biotech's Debt-to-Asset for the quarter that ended in Aug. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech  (OTCPK:IVBT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Innovation1 Biotech Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovation1 Biotech (Innovation1 Biotech) Business Description